GenVec Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Gaithersburg MD United States (1992)
Status: Acquired by Intrexon (2017)

Organization Overview

First Clinical Trial
2003
NCT00051480
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree